| 2023-12-07 | +0.16 % |
|
| 2023-12-06 | +0.42 % |
|
| 2023-12-05 | +0.18 % |
|
| 2023-12-04 | +0.45 % |
|
| 2023-12-01 | +2.16 % |
|
| 2023-11-29 | +0.21 % |
|
| 2023-11-28 | -0.07 % |
|
| 2023-11-27 | -1.56 % |
|
| 2023-11-22 | +0.23 % |
|
| 2023-11-20 | -0.16 % |
|
| 2023-11-17 | +0.4 % |
|
| 2023-11-15 | +1.27 % |
|
| 2023-11-14 | +3.58 % |
|
| 2023-11-10 | +2.01 % |
|
| 2023-11-09 | -1.7 % |
- FedEx (FDX) stock went down by 1.7% last night, possibly due to fraying U.S.-China relations and the end of the "panda diplomacy" experiment that involved the transportation of pandas from the U.S. to China.
- The article discusses a unique metric called the "DC Insider Score" introduced by Quiver Quantitative, which quantifies the ties between companies and the US government based on congressional stock trading, corporate lobbying, and government contracts. According to this ranking system, the top five companies with close ties to the US government are Pfizer, Ford, Lockheed Martin, Honeywell, and Microsoft. FedEx is also mentioned as a company with considerable presence in these categories. The article does not provide an explanation for why the FedEx stock went down, so it is not clear why this happened.
- FedEx (FDX) stock went down by 1.7% due to Principal Financial Group Inc. reducing its position in the company and selling shares worth $64,308,000, as well as other hedge funds adding to or reducing their stakes in the company.
|
| 2023-11-07 | -0.46 % |
|
| 2023-11-06 | -0.73 % |
|
| 2023-11-03 | -0.04 % |
|
| 2023-11-02 | +1.65 % |
- FedEx (FDX) stock went up by 1.65% last night. The CEO of FedEx, Raj Subramaniam, cited several reasons for the stock's increase, including the normalization of consumer spending on goods and services, the normalization of e-commerce ordering levels, and the end of inventory destocking among big retailers. Subramaniam also mentioned that despite a volume decline, FedEx's operating profits have increased in the past year, making it the first time that has happened during a demand downturn in the company's history. However, Subramaniam remains cautious about the global trade environment and is waiting for inventory restocking to take place in the coming months.
- The article discusses how FedEx's stock went up by 1.65%, and suggests that the reasons for this increase could be due to the fact that the worldwide recession, which was previously predicted by FedEx CEO Raj Subramaniam, has not yet materialized.
|
| 2023-11-01 | +1.3 % |
|
| 2023-10-31 | +1.39 % |
|
| 2023-10-30 | +3.49 % |
|
| 2023-10-27 | +0.4 % |
|
| 2023-10-26 | -3.1 % |
|
| 2023-10-25 | -2.68 % |
|
| 2023-10-24 | +1.56 % |
|
| 2023-10-23 | -1.1 % |
|
| 2023-10-20 | -1.1 % |
|
| 2023-10-18 | -1.78 % |
|
| 2023-10-16 | +1.94 % |
|
| 2023-10-13 | -3.65 % |
|
| 2023-10-12 | -1.34 % |
|
| 2023-10-11 | -0.52 % |
|
| 2023-10-10 | +0.42 % |
|
| 2023-10-09 | -0.85 % |
|
| 2023-10-06 | -0.49 % |
|
| 2023-10-05 | -0.34 % |
|
| 2023-10-04 | -0.05 % |
|
| 2023-10-03 | -1.86 % |
|
| 2023-10-02 | +0.07 % |
|
| 2023-09-29 | -0.57 % |
|
| 2023-09-28 | +1.42 % |
|
| 2023-09-27 | +0.5 % |
|
| 2023-09-25 | +2.05 % |
- The article states that FedEx stock (FDX) has seen a 2.05% increase, but it is currently trading at $262 per share, 8% below the level seen in March 2021, and it is believed that the stock has little room for growth. The reason for the recent increase in FedEx stock is not mentioned in the article.
- FedEx (FDX) stock went up by 2.03% due to gains in major U.S. stock indices, including the Dow industrial average, S&P index, and NASDAQ index, following a decline in the previous three weeks.
- The article discusses the clinical trial supply and logistics market for pharma, stating that it is valued at $13.8 billion in 2023 and projected to grow at a CAGR of 8.4% during the forecast period. The globalization of clinical trials and the shift towards personalized medicine are driving the need for robust global supply chain networks and more agile supply chain models. The COVID-19 pandemic has had a significant impact on clinical trials, causing disruptions to the manufacturing and distribution processes due to lockdown measures, travel restrictions, and workforce shortages. Pharmaceutical companies have implemented strategies such as remote monitoring, diversification of suppliers, and prioritization of resources to navigate these challenges. The rise of personalized medicine and expansion into emerging markets are identified as market drivers, while advanced analytics and predictive modeling are seen as opportunities for pharmaceutical companies to enhance their forecasting accuracy and optimize their supply chains.
|
| 2023-09-22 | -0.29 % |
|
| 2023-09-21 | +4.52 % |
|
| 2023-09-20 | +0.21 % |
|
| 2023-09-19 | +0.28 % |
|
| 2023-09-18 | -1.88 % |
|
| 2023-09-15 | -1.15 % |
|
| 2023-09-13 | +0.27 % |
|
| 2023-09-12 | -1.27 % |
|
| 2023-09-08 | -1.11 % |
|
| 2023-09-05 | -1.67 % |
|
| 2023-09-01 | -0.02 % |
|
| 2023-08-30 | +1.27 % |
|
| 2023-08-29 | +0.86 % |
|
| 2023-08-28 | -0.15 % |
|
| 2023-08-25 | -0.02 % |
|
| 2023-08-24 | -0.64 % |
|
| 2023-08-22 | -0.37 % |
|
| 2023-08-21 | -1.03 % |
|
| 2023-08-18 | -0.85 % |
|
| 2023-08-17 | -0.06 % |
|
| 2023-08-16 | -0.18 % |
|
| 2023-08-15 | -0.52 % |
- The article discusses the recent agreement between United Parcel Service (UPS) and the Teamsters, highlighting the benefits for UPS employees and solidifying UPS's position as a leading logistics provider; however, it also mentions that FedEx has not seen any immediate material benefits from the UPS labor negotiations, but is optimistic about potential long-term opportunities. The reason for FedEx's stock going down is unclear, as the article does not provide specific information about it.
- The article discusses Michael Burry's bet of over $1.6 billion that the stock market is going to crash and mentions that the stock market is ripe for a crash. It suggests that the stock market should not be booming given the struggling economy, citing declines in trucking services and package delivery demand. The author concludes by questioning whether Burry will be correct and highlights the dire state of the global economy.
- The article discusses the tech-stock purchases made by David Tepper's Appaloosa Management in the second quarter, including large positions in companies like Advanced Micro Devices, Intel, and Apple, while also reducing positions in energy companies and exiting positions in companies like Tesla, Disney, and Salesforce; it does not mention why FedEx's stock went down.
|
| 2023-08-11 | -0.29 % |
|
| 2023-08-09 | -1.04 % |
|
| 2023-08-08 | +1.48 % |
|
| 2023-08-07 | +0.52 % |
|
| 2023-08-02 | -1.01 % |
|
| 2023-08-01 | -0.66 % |
|
| 2023-07-27 | -1.03 % |
|
| 2023-07-25 | +0.34 % |
|
| 2023-07-24 | -0.35 % |
|
| 2023-07-21 | -1.47 % |
|
| 2023-07-20 | +1.26 % |
|
| 2023-07-18 | +2.84 % |
|
| 2023-07-11 | +2.67 % |
|
| 2023-07-03 | -0.14 % |
|
| 2023-06-30 | -0.83 % |
|
| 2023-06-29 | +0.62 % |
|
| 2023-06-28 | +0.68 % |
|
| 2023-06-27 | +5.04 % |
|
| 2023-06-23 | -0.25 % |
|
| 2023-06-22 | +3.14 % |
|
| 2023-06-21 | -2.51 % |
|
| 2023-06-20 | -0.78 % |
|
| 2023-06-16 | -1.26 % |
|
| 2023-06-15 | +2.95 % |
|
| 2023-06-14 | +0.35 % |
|
| 2023-06-13 | +1.92 % |
|
| 2023-06-08 | +0.18 % |
|
